Parkinson's vaccine trial aims to slow disease progression
Disease control
Ongoing
This study tests a vaccine called ACI-7104.056 in 150 people with early-stage Parkinson's disease. The goal is to see if it is safe and helps the body fight a protein linked to Parkinson's. Participants must already be on stable low-dose levodopa. This is not a cure, but may help…
Phase: PHASE2 • Sponsor: AC Immune SA • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC